title: RETRACTED: Ameliorative potential of linagliptin and/or calcipotriol on bleomycin-induced lung fibrosis: In vivo and in vitro study.
abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
  This article has been retracted due to the authors’ plagiarism of text and images from the work of Eman Said Abd-Elkhalek, Hatem Abdel-Rahman Salem, Ghada Mohamed SuddeK, Marwa Ahmed Zaghloul and Ramy Ahmed Abdel-Salam, Faculties of Pharmacy and Medicine, Mansoura University, Mansoura, Egypt.
authors.affiliation: Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. Electronic address: drakabel@gmail.com.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Kabel
authors.affiliation: Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
authors.forename: Maaly A
authors.initials: MA
authors.lastname: Abd Elmaaboud
authors.affiliation: Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
authors.forename: Aliaa
authors.initials: A
authors.lastname: Atef
authors.affiliation: Senior Medical Student, Faculty of Medicine, Taif University, Taif, Saudi Arabia.
authors.forename: Mohammed H
authors.initials: MH
authors.lastname: Baali
mesh_terms: D000818:Animals; D001761:Bleomycin / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004359:Drug Therapy, Combination; D066298:In Vitro Techniques; D000069476:Linagliptin / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D001761:Bleomycin; C055085:calcipotriene; D000069476:Linagliptin; D002117:Calcitriol
keywords: Bleomycin; Calcipotriol; Linagliptin; Pulmonary fibrosis; Study